News & Updates
Filter by Specialty:

Self-efficacy high among survivors of prostate cancer
01 May 2025
byStephen Padilla
Long-term prostate cancer survivors report high levels of self-efficacy, but the contrary is true for subgroups who are facing some challenges, a study presented at EAU 2025 has found.
Self-efficacy high among survivors of prostate cancer
01 May 2025
SC vs IV pembrolizumab: Which route is better for metastatic NSCLC?
30 Apr 2025
byStephen Padilla
In patients with treatment-naive metastatic nonsmall cell lung cancer (NSCLC), subcutaneous (SC) pembrolizumab (pembro) demonstrates comparable efficacy to that of intravenous (IV) pembro as regards overall exposure and trough concentration, reports a study presented at ELCC 2025.